Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Foundation Medicine, Inc. (FMI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/27/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
09/18/2018 |
10-Q/A
| Quarterly Report for the period ended June 30, 2018 [amend] |
08/10/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
08/09/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
08/03/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/03/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/03/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/03/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/03/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/02/2018 |
4
| ROCHE HOLDINGS INC (10% Owner) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Bought 13,877,949 shares
@ $137, valued at
$1901.3M
Bought 2,343,078 shares
@ $137, valued at
$321M
|
|
08/02/2018 |
4
| Yeshwant Krishna (Director) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 5,786 shares
@ $137, valued at
$792.7k
|
|
08/02/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 6,955 shares
@ $137, valued at
$952.8k
Disposed of 42,215 shares
@ $137, valued at
$5.8M
Unknown transaction of 1,562 options to buy
@ $7.12, valued at
$11.1k
|
|
08/02/2018 |
4
| Pellini Michael J (Director) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 103,711 shares
@ $137, valued at
$14.2M
Unknown transaction of 6,949 options to buy
@ $0.84, valued at
$5.8k
Unknown transaction of 30,548 options to buy
@ $0.84, valued at
$25.7k
Unknown transaction of 49,224 options to buy
@ $4.16, valued at
$204.8k
Unknown transaction of 25,625 options to buy
@ $7.12, valued at
$182.5k
|
|
08/02/2018 |
4
| Miller Vincent A. (Chief Medical Officer) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 30,993 shares
@ $137, valued at
$4.2M
Disposed of 36,186 shares
@ $137, valued at
$5M
Unknown transaction of 14,271 options to buy
@ $29.94, valued at
$427.3k
|
|
08/02/2018 |
4
| JONES EVAN/ FA (Director) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 17,652 shares
@ $137, valued at
$2.4M
Unknown transaction of 9,300 shares
@ $137, valued at
$1.3M
Unknown transaction of 6,252 options to buy
@ $4.16, valued at
$26k
Unknown transaction of 4,922 options to buy
@ $7.12, valued at
$35k
Unknown transaction of 13,385 options to buy
@ $24.21, valued at
$324.1k
|
|
08/02/2018 |
4
| Hesslein Robert W. (SVP and General Counsel) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 76,494 shares
@ $137, valued at
$10.5M
Disposed of 28,709 shares
@ $137, valued at
$3.9M
|
|
08/02/2018 |
4
| Fiedler Konstantin (COO) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 3,253 shares
@ $137, valued at
$445.7k
Disposed of 23,582 shares
@ $137, valued at
$3.2M
|
|
08/02/2018 |
4
| DOUGHERTY MICHAEL R (Director) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 12,120 shares
@ $137, valued at
$1.7M
Disposed of 12,669 shares
@ $137, valued at
$1.7M
|
|
08/02/2018 |
4
| Doherty Michael J (Head of Product Development) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 15,955 shares
@ $137, valued at
$2.2M
Disposed of 65,332 shares
@ $137, valued at
$9M
|
|
08/02/2018 |
4
| Cox Troy (President and CEO) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 35,221 shares
@ $137, valued at
$4.8M
Disposed of 206,847 shares
@ $137, valued at
$28.3M
|
|
08/02/2018 |
4
| Civik Thomas (Chief Commercial Officer) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Disposed of 33,421 shares
@ $137, valued at
$4.6M
|
|
08/02/2018 |
4
| Borisy Alexis (Director) has filed a Form 4 on Foundation Medicine, Inc.
Txns:
| Unknown transaction of 73,173 shares
@ $137, valued at
$10M
Unknown transaction of 13,385 options to buy
@ $24.21, valued at
$324.1k
|
|
08/02/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
07/31/2018 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
07/31/2018 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
07/31/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
07/31/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
07/31/2018 |
SC 13D/A
| ROCHE HOLDING LTD reports a 100% stake in Foundation Medicine, Inc. |
07/31/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
07/27/2018 |
GN
| New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix — Factors of Influence, Major Initiatives and Sustained Production |
07/18/2018 |
10-Q/A
| Quarterly Report for the period ended March 31, 2018 [amend] |
07/17/2018 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
07/17/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
07/17/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|